ABVC BioPharma, Inc. Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ABVC BioPharma, Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2024-09-30 was $34.54K, a 98.10% decline year-over-year.
- ABVC BioPharma, Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2024-06-30 was $102.11K.
- ABVC BioPharma, Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2023-09-30 was $1.81M.
- ABVC BioPharma, Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2021-09-30 was $2.69M.
- ABVC BioPharma, Inc. stock issued during period, value, conversion of convertible securities for fiscal 2023 was $1.79M.
- ABVC BioPharma, Inc. stock issued during period, value, conversion of convertible securities for fiscal 2020 was $1.72M.
- ABVC BioPharma, Inc. stock issued during period, value, conversion of convertible securities for fiscal 2012 was $0.00.
- ABVC BioPharma, Inc. stock issued during period, value, conversion of convertible securities for fiscal 2011 was $0.00.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2024-09-30 | $34.54K 10-Q/A · filed 2026-03-03 | |
| 2024-06-30 | $102.11K 10-Q · filed 2025-08-13 | |
| 2023-12-31 | $1.79M 10-K · filed 2025-04-15 | |
| 2023-09-30 | $1.81M 10-Q · filed 2024-11-14 | |
| 2021-09-30 | $2.69M 10-Q · filed 2021-11-15 | |
| 2020-12-31 | $1.72M 10-K · filed 2022-03-31 | |
| 2012-09-30 | $0.00 10-K · filed 2015-04-16 | |
| 2011-09-30 | $0.00 10-K · filed 2015-04-15 |